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Since the (re)discovery of cytochrome c (cyt c) in the early 1920s and subsequent detailed characterization of its structure and function in
mitochondrial electron transport, it took over 70 years to realize that cyt c plays a different, not less universal role in programmed cell death, apoptosis, by
interacting with several proteins and forming apoptosomes. Recently, two additional essential functions of cyt c in apoptosis have been discovered that
are carried out via its interactions with anionic phospholipids: a mitochondria specific phospholipid, cardiolipin (CL), and plasma membrane
phosphatidylserine (PS). Execution of apoptotic program in cells is accompanied by substantial and early mitochondrial production of reactive oxygen
species (ROS). Because antioxidant enhancements protect cells against apoptosis, ROS production was viewed not as a meaningless side effect of
mitochondrial disintegration but rather playing some – as yet unidentified – role in apoptosis. This conundrum has been resolved by establishing that
mitochondria contain a pool of cyt c, which interactswithCL and acts as a CL oxygenase. The oxygenase is activated during apoptosis, utilizes generated
ROS and causes selective oxidation of CL. The oxidized CL is required for the release of pro-apoptotic factors frommitochondria into the cytosol. This
redox mechanism of cyt c is realized earlier than its other well-recognized functions in the formation of apoptosomes and caspase activation. In the
cytosol, released cyt c interacts with another anionic phospholipid, PS, and catalyzes its oxidation in a similar oxygenase reaction. Peroxidized PS
facilitates its externalization essential for the recognition and clearance of apoptotic cells by macrophages. Redox catalysis of plasma membrane PS
oxidation constitutes an important redox-dependent function of cyt c in apoptosis and phagocytosis. Thus, cyt c acts as an anionic phospholipid specific
oxygenase activated and required for the execution of essential stages of apoptosis. This review is focused on newly discovered redox mechanisms of
complexes of cyt c with anionic phospholipids and their role in apoptotic pathways in health and disease.
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unhappy in its own way.” Lev Tolstoy, “Anna Karenina”
As discerning as the above principle postulated by Lev
Tolstoy is in describing societal interactions, it is entirely
inapplicable on a cellular level. In fact, quite the opposite can
be said about cells: all happy cells are happy in their own
well differentiated ways, while unhappy, injured cells are all
alike in the ways they end their life through two major death
pathways — necrosis or apoptosis. Decoding these pathways,
particularly apoptosis has become one of the important foci of
cell biology research and new important details are incessantly
emerging. This review concentrates on a new role that
cytochrome c (cyt c) complexes with anionic phospholipids –
a mitochondria-specific phospholipid, cardiolipin (CL), and
plasma membrane phosphatidylserine (PS) – play in apoptotic
signaling. We will consider newly discovered pathways through
which complexes of cyt c with CL and PS, respectively act as a
mitochondrial “sensor” during the execution phase of apoptosis
and/or as an externalized plasma membrane “eat-me” signal
during apoptotic corpse removal (programmed cell clearance).
Some of the implications for these lipid-dependent signaling
events in human disease will also be discussed.
1. Electron donor/acceptor functions of cytochrome c in
mitochondria
Cyt c is an abundant hemoprotein whose concentration in the
intermembrane space of mitochondria may be as high as 0.5–
1.0 mM [1]. This renders cyt c an effective shuttle of electrons
between respiratory complexes III and IV, a function essential
for uninterrupted energy metabolism. The quantitatively
significant presence of cyt c at the mitochondrial membrane
crossroads also makes it a potentially important participant of
other redox reactions in which not only its electron acceptor/
donor features but its catalytic properties are essential. Both
participation in electron transport and action as an oxidant of
superoxide radicals (a newly ascribed antioxidant function of
cyt c [2]) are based on tunneling of electrons to its heme-iron
and do not require immediate interactions of the heme with the
electron donors, complex III or superoxide anion radicals,
respectively.
Hexa-coordinate arrangement of cyt c heme iron whereby
tetra-coordinate association with porphyrin and two additional
coordinate bonds with Met80 and His18, respectively, ideally fit
these electron donor/acceptor functions. In fact, the hexa-
coordinate structure precludes involvement of cyt c in other
duties, such as redox-catalysis of peroxidase reactions, typical
of many hemoproteins [3,4]. In line with this, peroxidase
activity of solubilized cyt c is very low [5]. Interestingly, Met80
can undergo oxidative modifications resulting in loss of cyt c's
hexa-coordinate state [6,7]. Not surprisingly, oxidants – H2O2,
organic hydroperoxides – can convert cyt c into a peroxidase
via oxidation of its Met80 [8–10]. However, the physiological
relevance of these harsh oxidative conditions resulting in
modified forms of cyt c with pronounced peroxidase activity
remained uncertain. It has been known for a long time thatdifferent negatively charged membrane-active molecules such
as detergents and some phospholipids can bind to cyt c in model
systems and stimulate its peroxidase activity [11,12]. The
importance of cyt c conversion into a peroxidase in vivo is not
fully understood.
2. Cardiolipin binding confers peroxidase activity on
cytochrome c
Recently, we have reported that CL, which is essential for
normal functions of several mitochondrial protein complexes
[13–16], avidly binds to cyt c resulting in an extraordinary
enhancement of its catalytic peroxidase activity [17]. The
binding includes initial electrostatic attractions of positively
charged Lys residues (likely 72 and 73) with negatively
charged phosphate groups on CL followed by hydrophobic
interactions of one of the polyunsaturated fatty acid residues of
CL with a hydrophobic pocket of cyt c [18]. Tight interaction
between cyt c and CL likely involves formation of the
hydrogen bond between CL and Asn52 in cyt c [18]. The
binding constants of cyt c with different polyunsaturated
molecular species of CL are very high (on the order of
109 M−1); thus the complexes produced cannot be easily
dissociated by disruptors of electrostatic interactions such as
high ionic strength conditions [147].
Cyt c has a highly conserved primary structure across
different species. As shown in Fig. 1, a particular segment of the
cyt c molecule that includes Met80 as well Lys72, Lys73 and
Tyr48, Tyr67, Tyr74 remains invariant in different species.
Because these particular amino acid residues are essential for
either binding of cyt c with CL (Lys72, Lys73) or likely
participate in realization of its catalytic peroxidase activity
(Met80, Tyr48, Tyr67, Tyr74), it is tempting to speculate that this
peroxidase function and structural organization of cyt c once
emerged, remained evolutionary conserved.
In normal mitochondria, CL is confined to the inner (about
65% of total CL) and outer (about 35% of total CL) leaflets of
the inner mitochondrial membrane (IMM) whereas its presence
in the outer mitochondrial membrane (OMM) is negligible
[17,19,20]. Thus, physical contact between cyt c and CL can
only take place on the intermembrane surface of the outer IMM
leaflet. Furthermore, a significant fraction of CL is localized
within the contact sites between the IMM and OMM [21–23]
and is also engaged in interactions with other mitochondrial
proteins [13–16,24]. As a result, only a limited amount of CL is
available for binding with cyt c. Consequently, cyt c/CL
complexes normally represent only a small portion of both cyt c
(about 10–15%) and CL (2–3%) [17,25].
Recent focus on the involvement of CL in apoptosis
revealed that the triggering mechanisms engaging Bcl-2
family members require CL [22,23,26,27] and cause massive
trans-membrane migration of CL as well as its hydrolysis
[28,29]. Both peroxidation and hydrolysis of CL occur during
apoptosis and are important in its execution, particular in
release of pro-apoptotic factors [17,30]. One of the members
of the Bcl-2 family of proteins, Bid (more specifically,
truncated Bid or tBid), appears early in apoptotic
Fig. 1. Alignment of eukaryotic cytochrome C protein sequences. Species abbreviation and NCBI protein accession designations are indicated. S.c. (Saccharomyces
cerevisiae, yeast); D.m. (Drosophila melanogaster, fruitfly); A.g. (Anopheles gambiae, mosquito); X.t. (Xenopus tropicalis, frog); D.r. (Danio rerio, zebra fish); M.m.
(Mus musculus, mouse); and H.s. (Homo sapien, human). ClustalW alignment performed by MegAlign 5.0 (DNASTAR).
Fig. 2. ESI mass spectrometry of CL isolated from C57BL/6J mouse liver
mitochondria. CL was separated by 2D-HPTLC, extracted from the HPTLC
plate and subjected to electrospray ionization mass spectrometry by direct
infusion into a triple quadrupole mass spectrometer (TSQ70, Finnigan). Sheath
flow was adjusted to 5 μl/min and the solvent consisted of chloroform:methanol
(1:2, v/v). The electrospray probe was operated at a voltage differential of
−3.5 keV in the negative ion mode. Mass spectra were obtained by scanning in
the range of 200–1600 M/z. Source temperature was maintained at 70 °C. The
major species in mitochondria consisted of TLCL [(C18:2)4 CL], m/z 723.6 and
m/z 1448.5 for the double and single charge species, respectively. Other minor
species of CL [(C18:2)3, (C16:1)1],m/z 710.5 double andm/z 1423.8 single charge
species, respectively and [(C18:2)3, (C20:2)1], m/z 737.6 and m/z 1474.1 for
double and single charge species, respectively.
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migration of CL and its hydrolysis to mono-lyso-CL
[28,29]. During apoptosis, a significant enrichment of the
outer leaflet of IMM as well as of OMM with CL sets the
stage for its binding to cyt c and production of the CL/cyt c
complex with peroxidase activity.
3. Cytochrome c is a cardiolipin oxygenase
The peroxidase activity of cyt c/CL complexes reveals a
unique ability to selectively oxidize CL during apoptosis
[17,31] thus generating CL hydroperoxides (CL-OOH) required
for the release of pro-apoptotic factors from mitochondria into
the cytosol [17]. This critical role of CL oxidation in apoptosis
implies that its susceptibility to oxidation may control
progression of the apoptotic program. We established that,
unlike its polyunsaturated molecular species, mono-unsaturated
CLs are not readily oxidized by cyt c [17]. Thus changes in the
polyunsaturation pattern of CL molecular species may be
responsible for differential sensitivity of cells to pro-apoptotic
stimuli. In fact, different tissues display very specific patterns of
CL molecular species. Our novel lipidomics analysis data
indicate that mass spectra of liver CL are dominated by one
major peak (with m/z ratio of 724 for doubly charged and 1448
for singly charged ions) corresponding to tetralinoleoyl CL
(TLCL) (C18:4) (Fig. 2). In mass spectra of the brain CLs,
multiple peaks (with m/z ratios of 723.4, 738.5, 750.4, 762.1
and 774.4, for doubly-charged ions) are detectable (Fig. 3). The
MS–MS structural analysis identified several major molecular
species of CL in brain mitochondria as TLCL [(C18:2)4 CL]; C
(18:1)3C(20:4)1; (C16:0)1(C18:1)1(C20:4)1(C22:4)1; (C18:1)2(C20:4)1
(C22:6)1; C(18:0)1C(18:1)1C(22:6)2. This indicates that brain
mitochondria contain molecular species of CL with long-
chain polyunsaturated fatty acid residues (C20:4, C22:4, C22:6)
highly susceptible to oxidation (Fig. 3). It is tempting to
speculate that these specific features of brain CLs maydetermine, at least in part, their sensitivity to pro-apoptotic
stimulation by excitatory amino acids, catechols, etc. Interest-
ingly, several molecular species of polyunsaturated CL are also
found inDrosophila (with m/z 671.9, 685.4, 697.9, 711.8, 723.8
corresponding to (C16:1)4; (C16:1)3(C18:2); (C16:1)2(C18:2)2;
Fig. 3. ESI tandem mass spectrometry of CL isolated from mouse brain
mitochondria. CL was separated by 2D-HPTLC, extracted from the HPTLC
plate and subjected to electrospray ionization mass spectrometry by direct
infusion into a triple quadrupole mass spectrometer (Micromass, Inc.,
Manchester, England). Sheath flow was adjusted to 5 μl/min and the solvent
consisted of chloroform:methanol (1:2, v/v). The electrospray probe was
operated at a voltage differential of −3.5 keV in the negative ion mode. Mass
spectra for doubly charged CL species were obtained by scanning in the range of
400–950 M/z. Source temperature was maintained at 70 °C. (A) Typical
negative ion ESI mass spectrum of different molecular species of mouse brain
mitochondria cardiolipins. The major species in mouse brain consisted of TLCL
[(C18:2)4 CL], m/z 723.4; C(18:1)3C(20:4)1, m/z 738.5; (C16:0)1(C18:1)1(C20:4)1
(C22:4)1, m/z 750.4; (C18:1)2(C20:4)1 (C22:6)1, m/z 762.2; C(18:0)1C(18:1)1C(22:6)2,
m/z 774.4, all of which represent the (M-2H)2− species. Mass spectra
prototypical of 3 independent experiments are presented. (B) ESI tandem
mass spectrometry of CL, m/z 762.1. Daughter ions of linoleic acid (m/z 280.9),
arachidonic acid (m/z 302.9) and docosahexaenoic acid (m/z 326.6) fragments
are shown.
Fig. 4. Typical negative ion ESI mass spectrum of different molecular species of
Drosophila cardiolipins. Lipids were analyzed by electrospray ionization mass
spectrometry by direct infusion into a triple quadrupole mass spectrometer
(TSQ70, Finnigan). Sheath flow was adjusted to 5 μl/min and the solvent
consisted of chloroform:methanol (1:2, v/v). The electrospray probe was
operated at a voltage differential of −3.5 keV in the negative ion mode. Mass
spectra for doubly charged CL species were obtained by scanning in the range of
400–950 M/z. Source temperature was maintained at 70 °C. Different CL
molecular species present in Drosophila were observed (C16:1)4, m/z 671.9;
(C16:1)3(C18:2), m/z 685.4; (C16:1)2(C18:2)2, m/z 697.9; (C16:1)(C18:2)3, m/z 711.8;
(C18:2)4, m/z 723.8. Mass spectra prototypical of 3 independent experiments are
presented.
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CL oxidation may be involved in its apoptotic pathways as well.
On the other hand, cancer cells that contain more saturated
CL species may use this as a strategy to develop resistance to
pro-apoptotic stimuli and escape from apoptotic action of
antitumor drugs (Tyurin et al., unpublished data). In this
context, a recent study of tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL)-triggered apoptosis of
cancer cell lines has demonstrated a vital link between death
receptor signaling at the plasma membrane and changes in
mitochondrial membrane lipids (including CL) occurring before
or in parallel with the activation of apical caspases [29]. The
latter findings thus point towards new potential strategies foranti-cancer drugs that, by targeting cellular lipid metabolism,
could selectively kill cancer cells.
4. Role of cytochrome c peroxidase activity in apoptosis
The role of cyt c changes from mostly an electron-carrier in
normal mitochondria to mostly a CL-specific peroxidase
during apoptosis. The switch between these two functions is
due to cyt c's association with CL, whose availability at the
sites of location of cyt c sets the limit for peroxidase activity. It
is likely, that transmembrane migration of CL early in
apoptosis and its interaction with cyt c regulates peroxidase
activity of cyt c. Not surprisingly, siRNA-driven depletion of
cyt c results in proportionally enhanced resistance of cells to
apoptosis [17]. In line with this, our preliminary experiments
indicate that cyt c−/− mouse embryonic fibroblasts (MEF) cells
transfected with mutated cyt c (Met(80)Ala) exerted a higher
sensitivity to pro-apoptotic stimulation (Jiang et al, unpub-
lished results). Indeed, substitution of Met for Ala – which is a
weaker heme ligand than Met – facilitates access of H2O2 to
the heme catalytic site of cyt c and enhances its peroxidase
activity. Interestingly, the transgenic cyt c “knock-in” mouse
expressing cyt c that is defective (mutant) for interactions with
Apaf-1 and apoptosome activation, effectively supports
electron transport functions in mitochondria [32]. However,
the novel peroxidase function of cyt c described herein, and its
importance for apoptosis signaling in vivo, was not evaluated
in these studies.
Peroxidase activity of cyt c/CL complex requires H2O2 or
organic (lipid) hydroperoxides for catalytic oxidation of CL and
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factors that normally limit CL oxidation. Apoptosis is usually
accompanied by pronounced oxidative stress causing massive
production of ROS-superoxide radicals [33–35] whose dis-
mutation (spontaneous or catalyzed by mitochondrial Mn-SOD)
yield H2O2 [36–38]. Interestingly, a recent report described a
specific apoptosis-activated H2O2-generating role of p66 [39],
known to be an adaptor-protein in a tyrosine-kinase regulated
cascade in normal mitochondria [40].
GSH peroxidase, thioredoxin, glutaredoxin 2, and peroxy-
redoxin systems in mitochondria as well as catalase in
peroxisomes are important H2O2 regulators [41–44]. Genetic
manipulations of these H2O2-regulating systems have been
shown to affect sensitivity of cells to apoptosis [45–48].
Overexpression of mitochondrial antioxidant enzymes regulat-
ing phospholipid oxidation such as phospholipid hydroperoxide
glutathione peroxidase inhibits release of cyt c from mitochon-
dria by suppressing the peroxidation of CL thereby preventing
apoptosis [49,50]. Similarly, Enoksson et al. [51] showed that
mitochondrial glutaredoxin 2 can prevent CL oxidation and
thereby mitigates cyt c release. H2O2-regulating antioxidants,
particularly GSH and its precursors, are effective at inhibiting
apoptosis. Interestingly, another mitochondrial protein that has
been implicated in cell death, apoptosis-inducing factor (AIF)
[52,53] may realize its potential via control of GSH. The
oxidoreductase function of AIF is required for the maintenance
of GSH levels under conditions of cellular stress [54]. In light of
the dual roles of cyt c in the life and death of the cell, it is
instructive to also consider AIF as a potentially important redox
regulator of H2O2 and associated cyt c-dependent apoptotic
pathways.
5. Antioxidant regulation of cyt c/CL peroxidase activity
The heme-site in partially-unfolded cyt c/CL peroxidase
complex is accessible to small molecules, suggesting a
mechanism to regulate cyt c catalytic activity. Mitochondrial
reductants (e.g., ascorbate) may interact with the peroxidase
reactive intermediates (compounds I and II as well as with
protein-derived radicals) and, hence, inhibit CL peroxidation.
While this feat of ascorbate has been established for a number of
peroxidases, its role in the regulation of cyt c/CL-catalyzed
oxidations is not known. Another small-molecule regulator of
peroxidase activity, NO, can indeed effectively inhibit peroxi-
dase activity of cyt c/CL complexes. We demonstrated that
typical penta- and hexa-coordinate heme-nitrosyl complexes of
cyt c are readily formed in the presence of CL and prevent H2O2-
induced oxidation of polyunsaturated CL and other substrates in
simple biochemical model systems [148]. Provided these
reactions are realized in mitochondria during apoptosis,
mitochondrial NOS (mtNOS) and this NO-dependent mecha-
nism may serve a novel protective utility whose role and
functions remain conjectural [55]. Peroxynitrite, stemming from
interactions of NOS-generated NO with superoxide radicals
inadvertently formed by electron transport in mitochondria [56]
is a well-characterized inhibitor of mitochondrial functions [57].
Moreover, peroxynitrite causes nitration of MnSOD resulting inloss of its catalytic competence, so this adds another detrimental
aspect of dysregulated mtNOS [58]. Thus functions of NOS
cannot be considered protective in mitochondria. However,
combined with the role of p66 in specific mechanisms for H2O2
generation without intermediate production of superoxide [39],
effects of NO as scavengers of reactive intermediates of cyt c/CL
peroxidation may be essential in preventing accidental CL
oxidation and release of pro-apoptotic factors.
Because H2O2 is very important as a co-factor for the cyt c/
CL peroxidase reaction, prevention of its formation may be an
effective antiapoptotic strategy. Nitroxide radicals have ideal
chemical propensities for this function because they can act as
effective electron acceptors from components of mitochondrial
respiratory complexes [59]. As a result, nitroxides would
prevent formation of superoxide radicals and their dismutation
to H2O2. In addition, the product of nitroxide reduction,
nitroxide hydroxylamine, is a potent free radical scavenger
whose reaction with oxidizing radicals yields nitroxides. Thus
recycling of nitroxides, which occur during their radical
scavenging, may be important in their protective action. Not
surprisingly nitroxides have demonstrated significant protective
potency in different types of redox-driven disease conditions in
animal models [60–66]. Unfortunately the therapeutic potential
of nitroxides is difficult to exploit because it requires their very
high (mM) concentrations. One may assume that mitochondrial
targeting of nitroxides should lead to a significant decrease of
required protective concentrations. Recently, three successful
attempts have been reported in which different conjugates of
nitroxides directing them to mitochondria or cells resulted in a
several-fold decrease in nitroxide concentrations required to
exert antiapoptotic effects [17,67–69].
6. Oxidized CL binds to cyt c poorly resulting in release of
cyt c from mitochondria
CL oxidation designates an important stage of the execution
of apoptotic program because oxidized CL (in contrast to non-
oxidized CL) does not effectively bind cyt c [70,71]. As a result
of CL oxidation, cyt c is no longer retained by mitochondrial
membranes and can be released into the cytosol. Several reports
indicate that CL oxidation parallels and is required for the
release of cyt c and other proapoptotic factors from mitochon-
dria into the cytosol [72,73]. Further, the 2-step model of cyt c
release postulates that disruption of cyt c binding to CL within
mitochondria is followed by its release through pores in the
outer mitochondrial membrane likely involving interactions
with pro-apoptotic Bcl-2 family members such as Bax [25,30].
7. CL oxidation, cyt c release: implications for CNS diseases
Many CNS diseases are associated with oxidative stress and
lipid peroxidation [74–78]. For example, in the central nervous
system, programmed cell death contributes to neuronal death
after ischemia [79], epilepsy [80], and traumatic brain injury
[81]. Programmed cell death pathways have also been identified
in adults after stroke [82] and in pediatric patients dying of
sudden infant death syndrome [83]. Accumulation of
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demonstrated in early stages of several neurodegenerative
diseases as well as in brain trauma [84–86]. This identification
of isoprostanes – formed after de-esterification of peroxidized
phospholipids – in the disease process, however, does not
identify the origin of phospholipids from which they were
derived. Several studies indicate that CL is one of the important
oxidizable substrates, particularly in conditions associated with
enhanced apoptosis. For example, during nerve growth factor
(NGF) withdrawal-mediated neuronal apoptosis in vitro, Kirk-
land et al. [87] showed that CL concentration decreased to a
greater extent than did the concentrations of other more
abundant phospholipids (phosphatidylcholine (PC) or phospha-
tidylethanolamine (PE)). The decrease in CL content was
temporally associated with increased ROS production; aug-
mentation of cellular GSH concentration by NAC blocked loss
of CL, and the decrease in mitochondrial mass in NGF-deprived
neurons [87,88]. Similarly, in SOD1 mutant amyotrophic lateral
sclerosis (ALS) mice, cyt c binding was disrupted in
mitochondria, and mitochondrial lipids, including CL, were
found to be significantly more oxidized in mutant mice than in
wild-type animals [89]. The findings in ALS transgenic mice
are compatible with the novel oxygenase function of cyt c, as
proposed in the present review.
As important as these reported studies may be, they suffer
from a serious technical deficiency that quantitations of CL
concentrations and oxidation were made indirectly based on its
interactions with a fluorescent reagent, N-nonyl-acridine orange
(NAO) [87]. Recent assessments indicate that specificity of
NAO is not sufficient to accurately interpret its changes with CL
content and/or peroxidation [90,91]. Therefore, direct estimates
of CL oxidation are necessary to prove its participation in
neuronal apoptosis. In our preliminary experiments, we
demonstrated that CL oxidation occurs early in neuronal
apoptosis, and precedes cyt c release, PS externalization and
GSH depletion [92]. Moreover, direct MS and chromatographic
measurements of CL oxidation indicate that it may be used as an
important biomarker of apoptosis in vivo. In particular, in brain
trauma, selective CL oxidation occurs as one of the early
apoptotic biomarkers after traumatic brain injury [92].
8. Flirting of cytochrome c with PS results in PS oxidation
and externalization
Release of cyt c from mitochondria into the cytosol is
associated with the well-known central event in intrinsic
apoptosis signaling: the apoptotic protease-activating factor-1
(Apaf-1)-driven formation of apoptosomes and downstream
caspase activation designating a point-of-no-return in apoptosis
[93,94]. However, only a small fraction of cyt c is commonly
utilized in this process. Moreover, redox characteristics of cyt c
are not essential for this process [95]. Recent findings show that
the redox catalytic potency of cyt c is utilized in extra-
mitochondrial reactions of cyt c. Indeed, results obtained in in
vitro model systems have demonstrated that the peroxidase
catalytic competence of cyt c can also be realized with another
anionic phospholipid, PS [96,97]. In addition to CL, preferentialoxidation of PS, predominantly in the plasma membrane, is also
observed in cells undergoing apoptosis [98–101]. Notably, CL
oxidation and PS oxidation are temporally separated. PS
oxidation occurs before its externalization but after cyt c release
(Jiang et al., unpublished data). Finally, PS peroxidation is
blocked in cells overexpressing anti-apoptotic genes such as
Bcl-2 and is sensitive to pan-caspase inhibitors [98,99,102]. A
series of experiments in both intact cells and in vitro model
systems indicate that cyt c/PS complexes act as major catalysts
of PS oxidation during apoptosis [31]. Overall, these findings
support the notion that the execution of apoptosis involves
oxidative stress that also targets PS in the plasma membrane.
PS externalization is an essential “eat-me” signal for
macrophage engulfment of mammalian apoptotic cells [99,103].
Moreover, our studies have shown that the concomitant and
selective oxidation of PS also functions to generate crucial
recognition signals during programmed cell clearance [98–100].
Importantly, recent studies have confirmed the presence of
oxidized PS on the surface of apoptotic cells (in contrast, PE on
the cell surface was found not to be oxidized during apoptosis)
[104]. Furthermore, the mechanism of PS-dependent apoptotic
corpse clearance appears to have been conserved through
evolution [105].
Currently, externalization of PS is the only general
recognition ligand for phagocytes on apoptotic cell surface
[97,106]. However, recent studies have suggested that certain
proteins may also be exposed on the cell surface during
programmed cell clearance, including the PS-binding protein,
annexin I [107] and calreticulin, a protein that binds to LDL-
receptor related protein (LPR) on the engulfing cell and was
suggested to cooperate with PS as a recognition signal [108]. In
other words, engulfing cells evidently prefer a “high protein,
high fat” diet. Indeed, given that PS exists either as oxidized or
non-oxidized species on the surface of apoptotic cells [99,104],
phagocytes may prefer not simply “high fat” but rather a “high
rancid fat” diet. This adds a further degree of complexity to the
process of cell clearance, and may allow for a more selective
removal of cell corpses, without inadvertent engulfment of non-
apoptotic cells.
In addition to oxidized phospholipids, lysophospholipids
(LPC and LPS) act as chemotactic factors secreted from
apoptotic cells in a caspase-dependent manner and serve to
attract macrophages to sites of cell attrition [109]. Lysopho-
spholipids have also been identified as putative “eat-me” signals
on the apoptotic cell surface, which are recognized by naturally
occurring IgM antibodies [110]. Of note, oxidation of
phospholipids could represent a step on the way to their
hydrolysis and formation of lysophospholipids [111].
9. Regulation of inflammatory responses by PS and
oxidized PS
Inflammation is a beneficial host response to foreign
challenge or tissue damage that ultimately leads to recovery
from infection and to restoration of tissue structure and function
[112,113]. However, the inflammatory reaction sometimes
proceeds to a chronic state and can thus, paradoxically,
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persistence of leukocytes, including polymorphonuclear gran-
ulocytes or neutrophils, is a hallmark of chronic inflammation.
Indeed, the release of proteolytic enzymes, ROS, and other
harmful contents from activated neutrophils is believed to be
responsible for the tissue destruction evidenced in chronic
inflammatory conditions [114]. Neutrophil apoptosis at sites of
inflammation and the subsequent macrophage engulfment of
these cells is thought to constitute a mechanism of safe
clearance that may limit tissue injury. Of note, the process of
programmed cell clearance is not a passive event, but plays an
active role in the resolution of inflammation, through
production of anti-inflammatory cytokines such as TGF-β by
macrophages and downregulation of pro-inflammatory media-
tors such as TNF-α [115–117].
Chronic granulomatous disease (CGD) is a rare, inherited
condition characterized by severe recurrent bacterial and
fungal infections and an inability of neutrophils and other
phagocytes to generate ROS, which are needed for
intracellular killing of microorganisms; the underlying
genetic defect is a mutation in the NADPH oxidase [118].
Our previous in vitro studies have shown that phorbol ester-
triggered externalization of the “eat-me” signal PS is
defective in neutrophils obtained from CGD patients [119],
and one may speculate that the absence of this crucial
recognition signal on the surface of activated neutrophils
may disrupt the clearance of cells in vivo, thus contributing
to the formation of inflammatory granulomas and tissue
destruction evidenced in these patients. Indeed, an increased
accumulation of neutrophils was observed in peritoneal
exudates of NADPH oxidase (phox)-defective mice injected
with heat-inactivated bacteria, indicative of a clearance defect
in this model of CGD [120]. Our ongoing studies have
confirmed that NADPH oxidase-defective, PS-negative
neutrophils from CGD patients are poorly recognized by
normal macrophages, upon in vitro co-cultivation (Fadeel et
al., unpublished observations). In addition, macrophages
from CGD patients were shown to be severely compromised
in their ability to produce anti-inflammatory mediators such
as TGF-β [121], which may contribute to the persistence of
inflammation in this disease.
Recent technological developments in the field of nanoma-
terials and carbon nanotubes have enabled the study of their
toxicity, particularly to the lung [122,123]. Exposure of mice to
single walled carbon nanotubes induced an unusually robust
inflammatory response with a very early onset of pulmonary
fibrosis [122]. This has been associated with poor recognition of
non-functionalized carbon nanotubes by macrophages. Notably,
our studies showed that coating of nanotubes with PS (but not
with PC) resulted in a remarkable improvement in their
recognition by macrophages suggesting that PS acts as an
“eat-me” signal not only on the surface of apoptotic cells but
also on nanotubes [124]. PS-dependent signaling changes
cytokine responses of macrophages from a pro-inflammatory to
an anti-inflammatory pattern [117,125]. Therefore, PS-coated
nanotubes may be utilized as a novel tool for the regulation of
inflammatory responses [126].Circulating anti-phospholipid antibodies in patients with
systemic lupus erythematous and alcoholic liver disease
recognize and bind selectively to apoptotic, but not viable
cells [127,128]. Detailed analysis showed that the antibodies
were mainly directed towards oxidized phospholipids (CL and
PS) and that oxidation of phospholipids was essential to generate
epitopes for many anti-phospholipid antibodies [129]. Of note,
the recognition of apoptotic cells coated by anti-phospholipid
antibodies or other auto-antibodies through Fc receptors was
suggested to lead to pro-inflammatory macrophage responses
[130]. Thus, it is possible that anti-phospholipid antibodies
targeting externalized PS on apoptotic cells might favor
inflammatory processes, under certain pathological conditions.
10. Oxidized phospholipids, natural antibodies: implications
for atherogenesis
Atherosclerosis is widely recognized as a chronic inflam-
matory disease that encompasses both innate and adaptive
immune responses [131]. Although numerous risk factors have
been identified, atherosclerosis is clearly initiated and sustained
by hypercholesterolemia and associated elevations of serum
low-density lipoproteins (LDL). Once trapped in the vessel
wall, LDL may undergo modifications, including oxidation
(thus forming oxidized LDL, oxLDL), and the resulting
products can then activate inflammatory responses that further
promote atherogenesis [132,133]. Macrophages are central in
atherosclerosis; upon activation, these cells initiate the oxida-
tion of LDL and rapidly take up oxLDL through specific
scavenger receptors, leading to foam cell formation. Macro-
phages also secrete a variety of pro-inflammatory factors that
affect lesion progression.
Membranes of apoptotic cells are in many aspects similar to
oxLDL insofar as they contain increased levels of oxidized
phospholipids, including PS (discussed above). Chang and
colleagues [134] have shown that monoclonal antibodies
against oxLDL bind to the surface of apoptotic cells and inhibit
their uptake by macrophages, thus providing further evidence of
oxidation-specific epitopes on apoptotic cells. Moreover, C-
reactive protein (CRP) was recently found to bind both oxLDL
and “late” apoptotic cells (i.e., apoptotic cells that have
undergone secondary necrosis due to prolonged in vitro culture)
through recognition of a common ligand, oxidized phosphati-
dylcholine (PC) [135]. These oxidation-specific epitopes can be
considered as pathogen-associated molecular patterns (PAMPs),
and are recognized by natural antibodies and other innate
immune receptors, including scavenger receptors [131]. Natural
antibodies are thought to play a role in the recognition and
removal of senescent cells, cell debris, and other self-antigen,
and it has been hypothesized that this “house-keeping” role
against oxidation-dependent neoepitopes (including oxLDL)
[136] has contributed in large part to their evolutionary
selection. Natural antibodies were shown to block the uptake
of oxLDL by macrophages and could thus prevent foam cell
formation [137]. Similarly, these antibodies could perhaps play
a role in the programmed clearance of apoptotic and senescent
cells displaying similar oxidation-specific epitopes or PAMPs.
Fig. 5. War and peace: the manifold functions of cytochrome c. Cyt c is essential for oxidative phosphorylation and the production of ATP under normal conditions.
Moreover, as depicted in this diagram, cyt c plays several important roles during the execution and resolution stages of cell death. Hence, cyt c acts as a cofactor in the
activation of apoptosomes in the cytosol, resulting in the activation of downstream caspases. Cyt c has also recently been ascribed a novel function as a CL oxygenase
within mitochondria, and is thus implicated in the early steps of the apoptotic program. Finally, cyt cmay catalyze the peroxidation of plasma membrane phospholipids
including PS, leading to the exposition of recognition signals for macrophages and the engulfment of the cell corpse.
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with syngeneic apoptotic cells led to high titers of antisera that
reacted not only with apoptotic immunogens but also to a panel of
different oxidation-specific epitopes, including oxidized PC, that
are also found onoxLDL [138].Moreover, oxidized phospholipids
on apoptotic cells were shown to activate endothelial cells to
induce monocyte adhesion, a pro-inflammatory response (and a
rate-limiting step in atherosclerosis) that was abrogated by
antibodies specific for oxidized PC. Normally, apoptotic cell
corpses are swiftly removed by phagocytes without inciting an
inflammatory response (as discussed above). However, under
certain conditions, such as the pathological accumulation of
excessive numbers of dying cells, or an accumulation of dying
cells that exceeds the clearance capacity of the tissue, apoptosis
could also trigger inflammation [139]. One may speculate that the
oxidative modification of phospholipids that occurs during
apoptosis is a mechanism through which apoptotic cells could
promote pro-inflammatory responses [128,138]. Alternatively,
such responses could ultimately be protective by enhancing the
clearance of apoptotic cells through the recruitment (for instance
via LPC-dependent chemotaxis) of sufficient numbers of other
inflammatory (phagocytic) cells to the apoptotic lesion. Finally,
although oxidized phospholipids may promote chronic inflam-
mation in atherosclerosis, other data suggest that they can also
inhibit inflammation and protect mice from lethal endotoxin
shock [140]. Clearly, phospholipids (and more specifically, their
oxidatively modified counterparts) are involved in a range of
biological processes that are now gradually being unraveled
[141,142].
11. Concluding remarks
The multitude of molecular players in apoptosis and the
intricate interactions are reminiscent of the numerous characters
and the convoluted plots of many classic Russian novels.
However, cyt c has emerged as one of the key protagonists in
the drama of cellular suicide (apoptosis). In the present review,
we have described some of the novel roles of cyt c within and
outside of mitochondria that are associated with its redox
catalytic competence as a peroxidase specific for the anionic
phospholipids, CL and PS (Fig. 5).
The core death machinery has been conserved through
evolution, from worms to mammals [143]. However, cyt c
appears to be important as a co-factor for caspase activation
downstream of mitochondria only in mammalian cells, but notin the nematode (indeed, the C. elegans homolog of Apaf-1,
CED-4, lacks a cyt c-binding domain) [94]. Nevertheless, it
remains to be determined whether cyt c exerts other, conserved
roles in apoptosis also in nematodes and other model organisms,
for instance, in the facilitation of PS peroxidation during
programmed cell clearance. Similarly, the importance of cyt c as
a mitochondrial CL oxygenase has not been studied yet in non-
mammalian cells. Given the highly conserved domains of the
cyt c molecule important for its redox peroxidase function, it
could perhaps serve as a conserved mechanism for the release
from these organelles of pro-apoptotic factors, such as cyt c or
AIF (designated WAH-1 in C. elegans) [144].
Dysregulated apoptosis is common in human disease [145]:
excessive apoptosis is typical of degenerative diseases including
neurodegenerative diseases and immune deficiency states,
whereas insufficient apoptosis contributes to cancer and
autoimmune diseases. This emphasizes the urgency in devel-
oping new therapeutic approaches to control apoptosis. Indeed,
multiple attempts to use different antiapoptotic agents have been
included in drug discovery programs [145,146]. Thus, an
increasing number of compounds targeting a diverse range of
apoptosis-related molecules are being explored at the preclinical
and clinical levels. However, essentially all of these attempts are
based on the development of disruptors of protein–protein
interactions. The recent discovery, reported herein, of CL/cyt c
complexes involved in the execution of early stages of apoptosis
makes this a novel and attractive target for drug discovery. New
approaches could thus be envisioned based on the use of
disruptors of protein–lipid interactions, rather than of protein–
protein interactions, to yield effective antiapoptotic agents for
the treatment of human pathologies.
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